175 related articles for article (PubMed ID: 24862407)
1. Loss of Sparc in p53-null Astrocytes Promotes Macrophage Activation and Phagocytosis Resulting in Decreased Tumor Size and Tumor Cell Survival.
Thomas SL; Schultz CR; Mouzon E; Golembieski WA; El Naili R; Radakrishnan A; Lemke N; Poisson LM; Gutiérrez JA; Cottingham S; Rempel SA
Brain Pathol; 2015 Jul; 25(4):391-400. PubMed ID: 24862407
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of SPARC expression inhibits cell migration and invasion in malignant gliomas.
Seno T; Harada H; Kohno S; Teraoka M; Inoue A; Ohnishi T
Int J Oncol; 2009 Mar; 34(3):707-15. PubMed ID: 19212676
[TBL] [Abstract][Full Text] [Related]
3. Deletion of the SPARC acidic domain or EGF-like module reduces SPARC-induced migration and signaling through p38 MAPK/HSP27 in glioma.
McClung HM; Golembieski WA; Schultz CR; Jankowski M; Schultz LR; Rempel SA
Carcinogenesis; 2012 Feb; 33(2):275-84. PubMed ID: 22114076
[TBL] [Abstract][Full Text] [Related]
4. Distinct roles of CSF family cytokines in macrophage infiltration and activation in glioma progression and injury response.
Sielska M; Przanowski P; Wylot B; Gabrusiewicz K; Maleszewska M; Kijewska M; Zawadzka M; Kucharska J; Vinnakota K; Kettenmann H; Kotulska K; Grajkowska W; Kaminska B
J Pathol; 2013 Jul; 230(3):310-21. PubMed ID: 23520016
[TBL] [Abstract][Full Text] [Related]
5. SPARC: a signal of astrocytic neoplastic transformation and reactive response in human primary and xenograft gliomas.
Rempel SA; Golembieski WA; Ge S; Lemke N; Elisevich K; Mikkelsen T; Gutiérrez JA
J Neuropathol Exp Neurol; 1998 Dec; 57(12):1112-21. PubMed ID: 9862633
[TBL] [Abstract][Full Text] [Related]
6. SPARC functions as an anti-stress factor by inactivating p53 through Akt-mediated MDM2 phosphorylation to promote melanoma cell survival.
Fenouille N; Puissant A; Tichet M; Zimniak G; Abbe P; Mallavialle A; Rocchi S; Ortonne JP; Deckert M; Ballotti R; Tartare-Deckert S
Oncogene; 2011 Dec; 30(49):4887-900. PubMed ID: 21685937
[TBL] [Abstract][Full Text] [Related]
7. Enhanced growth of pancreatic tumors in SPARC-null mice is associated with decreased deposition of extracellular matrix and reduced tumor cell apoptosis.
Puolakkainen PA; Brekken RA; Muneer S; Sage EH
Mol Cancer Res; 2004 Apr; 2(4):215-24. PubMed ID: 15140943
[TBL] [Abstract][Full Text] [Related]
8. Malignant transformation of p53-deficient astrocytes is modulated by environmental cues in vitro.
Bögler O; Nagane M; Gillis J; Huang HJ; Cavenee WK
Cell Growth Differ; 1999 Feb; 10(2):73-86. PubMed ID: 10074901
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of secreted protein acidic and rich in cysteine (SPARC) expression diminishes radiosensitivity of glioma cells.
Liu H; Zhang H; Jiang X; Ma Y; Xu Y; Feng S; Liu F
Cancer Biother Radiopharm; 2011 Dec; 26(6):705-15. PubMed ID: 22145659
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of HSP27 alone or in combination with pAKT inhibition as therapeutic approaches to target SPARC-induced glioma cell survival.
Schultz CR; Golembieski WA; King DA; Brown SL; Brodie C; Rempel SA
Mol Cancer; 2012 Apr; 11():20. PubMed ID: 22480225
[TBL] [Abstract][Full Text] [Related]
11. SPARC regulates microgliosis and functional recovery following cortical ischemia.
Lloyd-Burton SM; York EM; Anwar MA; Vincent AJ; Roskams AJ
J Neurosci; 2013 Mar; 33(10):4468-81. PubMed ID: 23467362
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of Aquaporin-1 mediates a microglial phenotype switch affecting glioma growth.
Hu F; Huang Y; Semtner M; Zhao K; Tan Z; Dzaye O; Kettenmann H; Shu K; Lei T
Exp Cell Res; 2020 Nov; 396(2):112323. PubMed ID: 33058832
[TBL] [Abstract][Full Text] [Related]
13. HSP27 mediates SPARC-induced changes in glioma morphology, migration, and invasion.
Golembieski WA; Thomas SL; Schultz CR; Yunker CK; McClung HM; Lemke N; Cazacu S; Barker T; Sage EH; Brodie C; Rempel SA
Glia; 2008 Aug; 56(10):1061-75. PubMed ID: 18442089
[TBL] [Abstract][Full Text] [Related]
14. SPARC-induced increase in glioma matrix and decrease in vascularity are associated with reduced VEGF expression and secretion.
Yunker CK; Golembieski W; Lemke N; Schultz CR; Cazacu S; Brodie C; Rempel SA
Int J Cancer; 2008 Jun; 122(12):2735-43. PubMed ID: 18350569
[TBL] [Abstract][Full Text] [Related]
15. Reduced latency but no increased brain tumor penetrance in mice with astrocyte specific expression of a human p53 mutant.
Klein MA; Rüedi D; Nozaki M; Dell EW; Diserens AC; Seelentag W; Janzer RC; Aguzzi A; Hegi ME
Oncogene; 2000 Nov; 19(47):5329-37. PubMed ID: 11103934
[TBL] [Abstract][Full Text] [Related]
16. PTEN augments SPARC suppression of proliferation and inhibits SPARC-induced migration by suppressing SHC-RAF-ERK and AKT signaling.
Thomas SL; Alam R; Lemke N; Schultz LR; Gutiérrez JA; Rempel SA
Neuro Oncol; 2010 Sep; 12(9):941-55. PubMed ID: 20472716
[TBL] [Abstract][Full Text] [Related]
17. cDNA array analysis of SPARC-modulated changes in glioma gene expression.
Golembieski WA; Rempel SA
J Neurooncol; 2002 Dec; 60(3):213-26. PubMed ID: 12510773
[TBL] [Abstract][Full Text] [Related]
18. The p53/p21Cip1/ Waf1 pathway mediates the effects of SPARC on melanoma cell cycle progression.
Fenouille N; Robert G; Tichet M; Puissant A; Dufies M; Rocchi S; Ortonne JP; Deckert M; Ballotti R; Tartare-Deckert S
Pigment Cell Melanoma Res; 2011 Feb; 24(1):219-32. PubMed ID: 20955243
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus-mediated wild-type p53 expression induces apoptosis and suppresses tumorigenesis of experimental intracranial human malignant glioma.
Cirielli C; Inyaku K; Capogrossi MC; Yuan X; Williams JA
J Neurooncol; 1999 Jun; 43(2):99-108. PubMed ID: 10533721
[TBL] [Abstract][Full Text] [Related]
20. Losartan slows pancreatic tumor progression and extends survival of SPARC-null mice by abrogating aberrant TGFβ activation.
Arnold SA; Rivera LB; Carbon JG; Toombs JE; Chang CL; Bradshaw AD; Brekken RA
PLoS One; 2012; 7(2):e31384. PubMed ID: 22348081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
